Please assess the completion status of the following clinical trial:

Trial Title: A Pilot Clinical Trial of Oral Ketamine for Acute Pain Management After Amputation Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Adults of at least 18 years of age, but not older than 80 years~2. Due to undergo elective major amputation of the lower extremity (above the knee amputation (AKA), below the knee amputation (BKA), total knee amputation (TKA), transmetatarsal amputation (TMA), toe amputation) from all causes.~Exclusion Criteria:~1. Pregnancy~2. Increased intracranial pressure or intraocular pressure~3. Allergy to ketamine~4. Morbid obesity (BMI \> 40 kg/m2)~5. Significant comorbidity (ASA physical status classification \> 3)~6. Inability to communicate with the investigators~7. Any history of known or suspected drug or alcohol abuse~8. History of impaired liver function~9. Significant history of hallucinations, delusions or other psychiatric medical condition the investigator feels will prevent assessment of adverse events of study drug.~10. Significant psychiatric history; a diagnosis of schizophrenia, bipolar disorder, or severe depression.~11. Exposure to cytochrome P450 3A4 inhibitors or inducers (including grapefruit products) within 2 weeks before enrollment; the inability to avoid these products during ketamine administration.~12. Poorly-controlled hypertension

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Oral Ketamine (Type: EXPERIMENTAL): Subjects will receive Oral Ketamine (1.0 mg/kg) ) presurgery and 3 days postsurgery (including surgery day).

Based on this trial design, predict the completion outcome and termination type (if applicable).